The company is a modern pharmaceutical service industry group that serves the entire pharmaceutical industry chain. It also engages in pharmaceutical research and development, medical device production, and invests in the pharmaceutical industry. The company is listed on the Shenzhen Stock Exchange. The operating entity of the listed company, Chongqing Pharmaceutical (Group) Co., Ltd., formerly known as the Southwest Branch of China Pharmaceutical Company, was founded in 1950. It is a designated reserve unit for central and local second-level pharmaceuticals and medical devices. It is also one of only three domestic wholesale enterprises dealing in narcotic drugs and class 1 psychotropic drugs. It is leading in the western region in terms of enterprise size and market coverage. At this stage, the company is mainly engaged in pharmaceutical commerce, warehousing and logistics, pharmaceutical industry and R&D. Main products: pure hospital sales, commercial distribution, self-operated retail, terminal distribution, warehousing, logistics and supply chain value-added services for pharmaceuticals, medical devices, Chinese medicine tablets, and health care products. Corporate honors: Yuzhong District's “2018 Top 50 Tax Contributors”, “2016-2017 National Corporate Culture Outstanding Achievement” award, etc.